CRYO Cryo-Save

 

TIDMCRYO 
 
RNS Number : 3112Z 
Cryo-Save Group NV 
18 September 2009 
 

18 September 2009 
 
 
This announcement and the information contained herein is not for release, 
publication or distribution, directly or indirectly, in or into the United 
States, Australia, Canada, Japan, South Africa or any jurisdiction in which the 
same would be unlawful. This announcement is not an offer of securities in the 
United States, Canada, South Africa, Australia, Japan or any other jurisdiction. 
 
 
Cryo-Save Group NV 
 
 
Cryo-Save convenes EGM in relation to intended Euronext Amsterdam listing and 
proposed share consolidation 
 
 
Cryo-Save Group N.V. (AIM: CRYO, 'Cryo-Save or 'the Group'), Europe's leading 
stem cell bank, announces that an Extraordinary General Meeting of Shareholders 
(EGM) will be held on Monday, 5 October 2009 at 13.00 hours CET at 
IJsselpaviljoen, IJsselkade 1, 7201 HA Zutphen in relation to its intended 
Euronext Amsterdam listing and a proposed 5:1 share consolidation and 
redenomination. 
 
 
As set out in the Group's announcement on 3 September 2009, the Board of 
Directors envisages that the Euronext Amsterdam listing will bring increased 
visibility and liquidity. Cryo-Save will not be offering new shares in the 
context of, or concurrently with the Euronext Amsterdam Listing becoming 
effective. 
 
 
The Euronext Amsterdam listing requires several amendments to be made to the 
Group's articles of association, which require shareholders' approval. In 
connection with the Euronext Amsterdam listing the Group's shareholders will be 
requested to approve of certain other proposals as further described in the 
agenda for the EGM. 
 
 
In addition and separate to the proposals relating to the Euronext Amsterdam 
listing, the shareholders will be requested to approve a 5:1 consolidation and 
redenomination of the Group's shares. If the proposal is approved, the share 
consolidation will be effected after the close of trading on AIM on 7 October 
2009. Holders of depository interests can then expect the share consolidation to 
be reflected in their CREST accounts on 8 October 2009 as soon as practicable 
following the admission to trading of the shares on AIM on that date. 
 
 
The agenda, explanatory notes and proposed (amended) documents are available 
free of charge at the Group's offices in Zutphen, the Netherlands and can be 
downloaded from the Group's website, www.cryo-savegroup.com. 
 
 
The Group also announces that Johan Goossens has been granted the title 
of Chairman of the Board of Directors, following the appointment of Marc 
Waeterschoot as Chief Executive in July. 
 
 
 
 
The information contained herein is not for publication or distribution, 
directly or indirectly, in or into the United States of America (including its 
territories and possessions, any State of the United States and the District of 
Columbia).  These materials do not contain or constitute an offer for sale or 
the solicitation of an offer to purchase securities in the United States or any 
other jurisdiction. The securities mentioned herein have not been and will not 
be registered under the U.S. Securities Act of 1933, as amended (the "Securities 
Act"), and may not be offered or sold in the United States absent registration 
under the Securities Act or an available exemption from, or transaction not 
subject to, the registration requirements of the Securities Act. 
 
This announcement is not a prospectus. In connection with the contemplated 
admission of the shares in the capital of the Group to trading on Euronext 
Amsterdam by NYSE Euronext, a prospectus shall in due course be made generally 
available through the website of the Group (www.cryo-savegroup.com) and by 
sending a request in writing to the Group at its business address: IJsselkade 8, 
7201 HB Zutphen, the Netherlands 
 
 
 
 
+-------------------------------------+----------------------------------+ 
| For further details:                |                                  | 
+-------------------------------------+----------------------------------+ 
|                                     |                                  | 
+-------------------------------------+----------------------------------+ 
| Cryo-Save Group                     |             + 31 (0) 575 548998  | 
+-------------------------------------+----------------------------------+ 
| Marc Waeterschoot, Chief Executive  |                                  | 
| Arnoud van Tulder, Chief Financial  |                                  | 
| Officer                             |                                  | 
+-------------------------------------+----------------------------------+ 
|                                     |                                  | 
+-------------------------------------+----------------------------------+ 
| Daniel Stewart & Group plc          |           + 44 (0) 20 7776 6550  | 
+-------------------------------------+----------------------------------+ 
| Simon Leathers/Charlotte Stranner   |                                  | 
+-------------------------------------+----------------------------------+ 
|                                     |                                  | 
+-------------------------------------+----------------------------------+ 
| College Hill                        |           + 44 (0) 20 7457 2020  | 
+-------------------------------------+----------------------------------+ 
| Adrian Duffield/Rozi Morris         |                                  | 
+-------------------------------------+----------------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 NOEUWOARKURKAAR 
 

Cryo-Save (LSE:CRYO)
Gráfica de Acción Histórica
De Feb 2025 a Mar 2025

Cryo-Save (LSE:CRYO)
Gráfica de Acción Histórica
De Mar 2024 a Mar 2025